Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
5.58
+0.22 (4.10%)
At close: Apr 28, 2026, 4:00 PM EDT
5.40
-0.18 (-3.23%)
After-hours: Apr 28, 2026, 4:48 PM EDT
Atea Pharmaceuticals Market Cap
Atea Pharmaceuticals has a market cap or net worth of $444.57 million as of April 28, 2026. Its market cap has increased by 93.24% in one year.
Market Cap
444.57M
Enterprise Value
139.60M
1-Year Change
93.24%
Ranking
Category
Stock Price
$5.58
Market Cap Chart
Since the IPO on October 30, 2020, Atea Pharmaceuticals's market cap has decreased from $1.94B to $444.57M, a decrease of -77.06%. That is a compound annual growth rate of -23.51%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ginkgo Bioworks Holdings | 458.09M |
| Entrada Therapeutics | 454.68M |
| REGENXBIO | 452.17M |
| XOMA Royalty | 451.61M |
| Eupraxia Pharmaceuticals | 444.11M |
| Assembly Biosciences | 442.09M |
| Climb Bio | 436.60M |
| Lexeo Therapeutics | 433.41M |